Letter by Rustemi Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])".

Abstract

Sorry, we couldn't extract an abstract for this paper.
DOI: 10.1161/STROKEAHA.116.016512

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.